Incidence And Mortality Trend of Cervical Cancer in 11 Cancer Registries of China

Similar documents
Cancer Incidence and Mortality in China, 2007

Incidence and mortality of laryngeal cancer in China, 2011

Nasopharyngeal carcinoma incidence and mortality in China in 2010

Materials and Methods CACA. Original Article. Wan 鄄 Qing Chen, Rong 鄄 Shou Zheng and Si 鄄 Wei Zhang. Data source. Chinese Journal of Cancer

Analyses on Cancer Incidence and Mortality in Huai an Area, China, 2010

Cancer incidence and mortality in China in 2013: an analysis based on urbanization level

Estimated cancer incidence and mortality in Hebei province, 2012

Nasopharyngeal carcinoma incidence and mortality in China in 2009

Annual report on status of cancer in China, 2010

RESEARCH COMMUNICATION. No Incidence Trends and No Change in Pathological Proportions of Nasopharyngeal Carcinoma in Zhongshan in

Cancer incidence and mortality in China, 2014

Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006

ORIGINAL ARTICLE. Esophageal cancer incidence and mortality in China, 2009

Epidemiologic characteristics of cervical cancer in Korean women

Annual report on status of cancer in China, 2011

The updated incidences and mortalities of major cancers in China, 2011

Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou,

162 Biomed Environ Sci, 2014; 27(3):

Modelling the epidemiological impact of scaling up HIV testing and antiretroviral treatment in China

The Incidence and Mortality of Cervical Cancer in Ningbo during , China

Current cancer incidence and trends in Yaounde, Cameroon

Seasonal and geographical dispersal regularity of airborne pollens in China LI Quan-sheng, JIANG Sheng-xue, LI Xin-ze, ZHU Xiao-ming, WEI Qing-yu *

Time Trends of Nasopharyngeal Carcinoma in Urban Guangzhou over a 12-Year Period ( ): Declines in Both Incidence and Mortality

Biomed Environ Sci, 2015; 28(1): 80-84

Human Papillomavirus and Related Diseases Report CHINA

Nationwide Cancer Incidence in Korea,

Mortality from cancer of the lung in Serbia

EUROCHIP-II FINAL SCIENTIFIC REPORT ANNEX 08 REPORT OF ESTONIA

Prevalence of human papillomavirus infection of 65,613 women in East China

Invasive cancer of the cervix is considered a preventable disease because it has a long pre

Cancer Incidence in South-East Nigeria: A Report from Nnewi Cancer Registry

RESEARCH ARTICLE. Comparison between Overall, Cause-specific, and Relative Survival Rates Based on Data from a Population-based Cancer Registry

Downloaded from:

Chinese Anti-Cancer Association as a non-governmental organization undertakes systematic cancer prevention work in China

Trends in Lung Cancer Incidence by Histological Type in Osaka, Japan

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009

Trends in Nasopharyngeal Carcinoma Mortality in China,

The improved cure fraction for esophageal cancer in Linzhou city

Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013

Enterovirus 71 Outbreak in P. R. China, 2008

Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010

Prevalence and genotype distribution of human papillomavirus in women in the Henan Province

Avian Influenza A(H7N9) 13 February 2014 Surveillance Update

Relationship Between GSTT1 Gene Polymorphism and Hepatocellular Carcinoma in Patients from China

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

Cancer in Kuwait: Magnitude of The Problem

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54

Attributable Causes of Cancer in China: Fruit and Vegetable

HIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA

Cancer survival in Busan, Republic of Korea,

Changing trends in the incidence ( ) and mortality ( ) of cervical cancer in the Republic of Korea

Xinqiang Ji 1#, Yun Fang 2#, Jing Liu 1. Original Article

Emerging infectious disease: trends in the literature on SARS and H7N9 influenza

CORRELATION BETWEEN SURVIVIN OVEREXPRESSION AND CLINICO-PATHOLOGICAL FEATURES OF INVASIVE CERVICAL CANCER: A META-ANALYSIS

RESEARCH ARTICLE. Some Epidemiological Measures of Cancer in Kuwait: National Cancer Registry Data from

# For the GWAS stage, B-cell NHL cases which small numbers (N<20) were excluded from analysis.

Peking University People's Hospital, Peking University Institute of Hematology

Cancer Statistics in Korea: Incidence, Mortality and Survival in

Cancer Statistics in Korea: Incidence, Mortality and Survival in 2005

Analysis on Regional Difference of Narcotic Analgesic Medication in China Based on Data of

Cancer Institute & Hospital

Liver cancer and immigration: small-area analysis of incidence within Ottawa and the Greater Toronto Area, 1999 to 2003.

Cancer survival in Hong Kong SAR, China,

China. Key Data Issues and Suggestions

Public awareness of malaria at the beginning of a national malaria elimination program in China

Epidemiology of Gynecological Cancers in a Teritiary Care Center (Government General Hospital, Guntur

National Cancer Statistics in Korea, 2014

Original Article Application of AFP whole blood one-step rapid detection kit in screening for HCC in Qidong

Characteristics and trends in incidence of childhood cancer in Beijing, China,

Liver Cancer Screening in Korea: A Report on the 2008 National Cancer Screening Programme

Serological and molecular epidemiology of Japanese encephalitis virus infections in swine herds in China,

Cervical Cancer Screening and Analysis of Potential Risk Factors in 43,567 Women in Zhongshan, China

/Webpages/zhang/chinese-full full- program.htm

Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database

290 Biomed Environ Sci, 2016; 29(4):

The association between methylenetetrahydrofolate reductase gene C677T polymorphisms and breast cancer risk in Chinese population

Phase IV clinical trial of Shufeng Jiedu Capsule in the treatment of cases of acute upper espiratory infection of wind-heat syndrome

SHORT REPORT INCREASING COLORECTAL CANCER INCIDENCE RATES IN JAPAN

Breast cancer incidence and mortality: trends over 40 years among women in Shanghai, China

Human papillomavirus and vaccination for cervical cancer

High risk populations and HIV-1 infection in China

Esophageal cancer Study: China Story

Cancer survival in Seoul, Republic of Korea,

Aberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer

China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version)

Tuberculosis prevalence in China, ; a longitudinal analysis of national survey data

Research Article Changes in Etiologies of Hospitalized Patients with Liver Cirrhosis in Beijing 302 Hospital from 2002 to 2013

China HPAI Situation - Update

Supplementary Table 4. Study characteristics and association between OC use and endometrial cancer incidence

Report of China s innovation increase and research growth in radiation oncology

Epidemiological Features of Human Papillomavirus (HPV) Infection among Women Living in Mainland China

Normal Reference Value of Hemoglobin of Middleaged Women and Altitude

The data from the ATHENA study and others bring this expectation and the appropriateness of the guidelines for women aged into question.

Prediction of Cancer Incidence and Mortality in Korea, 2018

Cancer Profile in Patan District, Gujarat: A Comprehensive Review

China Country Advocacy Brief Injecting Drug Use and HIV

Construction of the Vesselcollateral. Guidance for Prevention and Treatment of Vasculopathy. Section 1. China. Clinical Trials.

Patterns and Trends with Cancer Incidence and Mortality Rates Reported by the China National Cancer Registry

Comparison of Survival Rates between Chinese and Thai Patients with Breast Cancer

The number of new cases is expected to rise by about 70% over the next 2 decades.

Transcription:

10 Chin J Cancer Res 23(1):10-14, 2011 www.springerlink.com Original Article And Trend of Cervical Cancer in 11 Cancer Registries of China Tao Lei 1, Wei-min Mao 1*, Tong-hai Lei 1, Li-qiong Dai 1, Luo Fang 1, Wan-qing Chen 2, Si-wei Zhang 2 1 The Zhejiang Cancer Hospital, Hangzhou 310022, China; 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical University, Beijing 100021, China DOI: 10.1007/s11670-011-0010-x Chinese Anti-Cancer Association and Springer-Verlag Berlin Heidelberg 2011 ABSTRACT Objective: In many countries, the cervical cancer prevalence has declined but less information about the changes is available in China. This study aims to understand the epidemiological characteristics and trend of cervical cancer in China. Methods: Cervical cancer data of 11 cancer registries during 1988-2002 in China were analyzed. The age and urban/rural differences and trend of cervical cancer incidence and mortality were described and discussed. Results: During 1988-2002, a total of 6007 incidence cases and 3749 mortality cases of cervical cancer were reported in the 11 cancer registries. The incidence crude rate of cervical cancer was 3.80/100,000 and the world age adjusted rate was 2.78/100,000. In the same period, the mortality crude rate was 2.37/100,000 and the world age adjusted rate was 1.66/100,000. Declined incidence and mortality trends were observed during this period in urban as well as in rural areas. When calculating the rates by age group, we found that the declining trends were only for older women and increasing trends for younger women, especially for women in the rural areas. Conclusion: The incidence and mortality rates declined during the period of 1988-2002 in China for older women. The younger women showed an increasing trend during the same period, especially for women in rural area. Key words: Cervical cancer; ; ; Trend; China INTRODUCTION Cervical cancer is a common malignant neoplasm of the cervix uteri in women. According to Globocan2002, the estimated incidence cases in the world was 493,243 with 83.0% of new cases in the less developed countries [1]. In recent decades, the incidence rates of cervical cancer showed a decreasing trend in many countries [2-4]. China, as a less developed country with huge population, the incidence and mortality rate of cervical cancer there was a decreasing trend in the period of 1970-1990 [5-6]. In Qidong, China, a relatively low incidence area of cervical cancer, there was a decreasing trend of incidence rate among aged women during the period of 1972-2000, according to population-based cancer registration data [7]. Due to the lack of valid data, the national analysis about cervical cancer prevalence was unavailable. In 1996, the Ministry of Science and Technology of the People s Republic of China set up a research program for national cancer registration, risk surveillance and risk 111111 Received 2010 08 25; Accepted 2010 11 25 This work was supported by the Eleventh Five Years Grant from the Ministry of Civil Affairs of China (No. 2008-47-2-10) * Corresponding author. E-mail: maowm1218@163.com assessment. It was finished in 2000. It was the first time to establish a nation wide network of cancer registration in China. The cancer registries have followed the international rules and standards, therefore, the data collected on the incidence and mortality of cervical cancer in this system over the past 15 years have provided an opportunity to study the time trends of cervical cancer in China. MATERIALS AND METHODS Data Source The cancer incidence and mortality data used in this study were based on a series of publications that included data from cancer registries in China for three periods of 1988-1992, 1993-1997, and 1998-2002. The related books were published in 2001, 2002 and 2007 respectively [8-10]. All cancer registries were population based and followed the rule and standard recommended by the International Agency for Research on Cancer (IARC) and the International Association for Cancer Registration. The details of methodology have been documented in the series publications by IARC [11-12]. In this study, the periods and coding used were same as above. All data of each cancer registry were reported to the National Cancer Research and Control Office for quality assessment and data analysis.

www.springerlink.com Chin J Cancer Res 23(1):10-14, 2011 11 Data collected included population, incidence cases, and mortality cases by 5 years age group, sex and area. For data consistence, this study selected data from 11 cancer registries that covered by all three volumes published by IARC. Those cancer registries included five cities, namely Beijing, Shanghai, Tianjin, Wuhan and Harbin, and seven counties, Cixian of Hebei province, Linzhou of Henan province, Qidong of Jiangsu province, Jiashan of Zhejiang province, Fusui of Guangxi province and Changle of Fujian province. For those 11 cancer registries, the analysis covered three periods, 15 years (1988-2002). Population Data For the 11 cancer registries during 1988-2002, the population covered 322,524,575 person-year, including 164,427,425 male (50.98%) and 158,097,150 female (49.02%), the sex ratio is 1.04; and 242,020,858 in cities (male: 123,242,963, female: 118,777,895, sex ratio=1.04), rural areas 80,503,717 (male: 41,184,462, female: 39,319,255, sex ratio=1.05). Among those, 13.97% were over 60 years old (male 12.73%, Female 15.22%). Data Analysis The statistical indicators included crude rate (CR), age-adjusted rate by world population (WSR), age-adjusted rate by Chinese standard population (CASR), age-specific rate, 35-64 truncated rate (35-64TR), 0-64 cumulative rate (0-64CUMR) and 0-74 cumulative rate (0-74CUMR) for incidence as well as mortality by sex. The 1985 world standard population and the 2000 Chinese standard population were used for age adjusting. Statistical software package SPSS 13.0 was used. RESULTS and Rates of Cervical Cancer in China During 1988-2002, a total of 6007 incidence cases and 3749 mortality cases of cervical cancer were reported in the 11 cancer registries. The incidence rate of cervical cancer was 3.80 per 100,000 for CR, 2.16 per 100,000 for CASR, 2.78 per 100,000 for WSR, 4.61 per 100,000 for 35-64 TR, 0.16% for 0-64 CUMR and 0.33% for 0-74 CUMR, respectively. In the same period, the mortality of cervical cancer was 2.37/100,000 for CR, 1.21/100,000 for CASR, 1.66/100000 for WSR, 1.97/100,000 for 35-64 TR, 0.07% for 0-64 CUMR and 0.19% for 0-74 CUMR (Table 1). Trend of and Rates In comparison between periods of 1988-1992 and 1998-2002, the incidence CR and WSR of cervical cancer decreased by 17.00% and 30.44% respectively; mortality CR and WSMR by 34.00% and 48.44% (Table 2 and Figure 1). Table 1. and mortality rates of cervical cancer in the period of 1988-2002 Case CR CASR WSR 0-64 CUMR% 0-74 CUMR% 35-64TR 6007 3.80 2.16 2.78 0.16 0.33 4.61 City 5030 4.23 2.25 2.92 0.16 0.35 4.60 Rural 977 2.48 1.76 2.20 0.15 0.24 4.50 3749 2.37 1.21 1.66 0.07 0.19 1.97 City 3050 2.57 1.21 1.67 0.06 0.19 1.79 Rural 699 1.78 1.17 1.56 0.09 0.17 2.58 Table 2. and mortality rates of cervical cancer in the period of 1988-2002 Period Case CR CASR WSR 0-64 CUMR% 0-74 CUMR% 35-64TR 1988-1992 2228 4.29 2.58 3.45 0.30 0.45 5.32 1993-1997 1876 3.56 2.00 2.59 0.14 0.32 3.74 1998-2002 1903 3.56 1.98 2.40 0.16 0.25 4.42 1988-1992 1495 2.88 1.63 2.25 0.16 0.27 2.50 1993-1997 1235 2.35 1.22 1.66 0.07 0.19 1.96 1998-2002 1019 1.90 0.86 1.16 0.05 0.11 1.38 Age Specific Rates of Cervical Cancer Cervical cancer was a typical aging disease with starting age from 15 and reached the peak at age group 75-79 and 5 years delay for mortality. Even though the ASIR and ASMR of cervical cancer showed a decreasing trend, the reversed changes were observed for women at middle age groups. In comparison between periods of 1988-1992 and 1993-1997, the age specific incidence rates showed an increase for age group under 45 years old and decreasing for 45 or old group. For those between periods of 1993-1997 and 1998-2002, the cut point was 55 years old. The mortality showed a similar trend as incidence (Table 3, Figures 2, 3).

12 Chin J Cancer Res 23(1):10-14, 2011 www.springerlink.com Figure 1. Trend of incidence rate of cervical cancer in the period of 1988-2002. Figure 2. Age specific incidence rate of ervical cancer by period Figure 4. Age-specific incidence rate of cervical cancer by area Figure 3. Age specific mortality rate of cervical cancer by period Figure 5. Age-specific mortality rate of Cervical cancer by area Figure 6. Trend comparison of incidence rate of cervical cancer among selected populations. Table 3. and mortality rates of cervical cancer by age group (1/100,000) 0-5- 10-15- 20-25- 30-35- 40-45- 50-55- 60-65- 70-75- 80-85- 1988-1992 0.00 0.00 0.00 0.00 0.18 0.21 0.77 0.55 1.39 3.47 5.11 8.33 18.05 22.35 29.26 30.08 21.27 15.58 1993-1997 0.00 0.00 0.00 0.03 0.33 0.69 1.42 1.16 2.45 2.76 3.49 5.03 9.65 15.32 21.34 23.55 19.57 10.90 1998-2002 0.00 0.00 0.00 0.07 0.11 1.35 4.34 3.05 4.19 4.54 5.07 3.56 4.75 7.69 11.04 13.77 16.84 9.80 Total 0.00 0.00 0.00 0.04 0.21 0.69 2.12 1.42 2.90 3.76 4.64 5.85 10.88 14.54 19.56 21.46 18.94 11.63 1988-1992 0.00 0.00 0.00 0.00 0.05 0.04 0.31 0.20 0.39 1.53 2.50 4.50 8.42 13.86 22.90 27.35 32.63 29.37 1993-1997 0.00 0.00 0.00 0.00 0.11 0.10 0.48 0.19 1.00 1.43 2.37 2.94 4.94 9.65 14.98 21.28 24.09 20.51 1998-2002 0.00 0.00 0.00 0.00 0.05 0.19 0.73 0.50 1.02 1.51 1.44 1.87 2.12 4.96 8.35 15.75 22.15 20.37 Total 0.00 0.00 0.00 0.00 0.07 0.10 0.50 0.28 0.86 1.49 2.05 3.22 5.20 9.14 14.63 20.76 25.66 22.71

www.springerlink.com Chin J Cancer Res 23(1):10-14, 2011 13 Table 4. and mortality rates of cervical cancer by area (1/100,000) 0-5- 10-15- 20-25- 30-35- 40-45- 50-55- 60-65- 70-75- 80-85- City 0.00 0.00 0.00 0.04 0.18 0.60 1.26 1.77 2.25 3.19 3.95 5.67 11.13 15.17 20.64 22.72 20.56 11.45 Rural 0.00 0.00 0.00 0.04 0.34 0.85 1.91 3.34 5.67 6.43 7.43 6.86 9.03 11.14 13.06 14.24 12.12 11.35 City 0.00 0.00 0.00 0.00 0.05 0.08 0.17 0.35 0.59 1.02 1.54 2.86 4.94 9.07 14.93 21.44 26.44 23.16 Rural 0.00 0.00 0.00 0.00 0.15 0.18 0.75 1.06 2.06 3.67 4.11 5.19 7.16 9.89 12.19 18.03 21.21 21.87 Table 5. Comparison of incidence rate of cervical cancer for the period of 1988-2002 Country/area 1988-1992 CR WSR 1993-1997 CR WSR 1998-2002 CR WSR USA/SEER White 9.76 7.63 8.88 6.85 7.90 6.50 Black 12.89 12.13 11.15 10.11 9.70 8.50 Japan/Osaka 12.96 9.29 10.88 7.22 8.70 5.60 Hongkong 17.12 15.34 15.12 12.34 13.30 9.80 China/This study 4.29 3.45 3.56 2.59 3.56 2.40 Singapore Chinese 16.67 16.17 16.95 15.18 14.40 11.50 USA/Los Angeles Chinese 8.61 7.54 7.29 5.44 7.00 4.90 Difference between City and Rural Area In comparison of the incidence of cervical cancer between city and rural area, the cervical cancer was 33% higher in urban than rural areas while and the mortality was slightly high (0.07%) in urban than rural areas (Table 1). To compare it by age group, for age under 60, the age specific rates of cervical cancer for women in rural areas were higher than that in city, but lower for women at 60 or older (Table 4, Figure 4). A similar trend like incidence was observed for age specific mortality rates with an extended cut point at 70 or older (Table 4, Figure 5). DISCUSSION The data used in this study were based on 11 cancer registries which were collaborative partners of a national program for cancer registration in China, and provided the most reliable, the largest comparable sample size and the longest period data source in China. In addition, the data of 11 cancer registries were accepted by IARC. As estimated the prevalence rate of cervical cancer in the world was 16.2 per 100,000 for incidence and 8.9 per 100,000 for mortality (10.3 per 100,000 and 6.4 per 100,000 in more developed countries; and 19.1 per 100,000 and 9.5 per 100,000 in less developed countries), respectively. We compared the incidence rates o cervical cancer in SEER program and Chinese of Los Angeles in the US, Osaka of Japan, Hongkong, China and Singapor Chinese, the rates of cervical cancer decreased worldwide including China, a country at a relative low level (Table 5 and Figure 6). Table 5 shows a comparison among different populations including SEER program and Chinese of Los Angeles in the United States of America, Osaka of Japan, Hongkong and Singapore Chinese. The incidence rate of cervical cancer decreased worldwide including China, a country at lower level (Table 5 and Figure 6). Although time trend of overall cervical cancer has been decreasing during the past 15 years, the rates of incidence or mortality have been increasing for young women. This study revealed a reversed trend in young women, particularly in rural area. It is very important for oncologist and health authorities to pay more attention to this phenomenon. An early cervical cancer-screening program in a population of 22,106 women aged over 25 years in a rural county of China indicated that the relative risk of cervix cancer was 0.33 in women with three or more negative smear tests [13], supporting the cervical cancer screening is an efficient method for cervical cancer control [14,15]. It has been reported that the immigrants in the United States would change their cancer patterns and rates from original countries to that in the new country after certain years and generations [16,17]. A number of factors may be associated with the development of cervical cancer. The most important risk factor for cervical cancer is human papillomaviruse (HPV) infection. A case- control study was conducted in Hubei, China and reported that HPV DNA was detected in 94.55% of patients with cervical cancer, and 23.64% of control subjects[ 18]. The risk of cervical cancer among women infected with HPV was 75.79 times greater than non-infected women. Due to the fact that the path of HPV infection is through sexual activities, resulting a constant increasing rates of sexual diseases and HPV infection during the same period of this study [19, 20], we assume that the increasing trend of cervical cancer in young women who are sexual active may be associated with high epidemic of HPV. Further studies are needed to explore the possible reasons for the increased trend of cervical cancer and control cervical cancer in China. In summary the incidence and mortality rates declined during the period of 1988-2002 in China, including urban

14 Chin J Cancer Res 23(1):10-14, 2011 www.springerlink.com and rural areas. When the data classified by age group, the declining trends only showed for older women. The younger women showed an increasing trend during the same period, especially for women in rural area. REFERENCES 1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer, and Prevalence Worldwide. Lyon: IARC Press; 2004. 2. Cornelison TL, Montz FJ, Bristow RE, et al. Decreased incidence of cervical cancer in medicare-eligible California women. Obstet Gynecol 2002; 100:79-86. 3. Howlett RI, Marrett LD, Innes MK, et al. Decreasing incidence of cervical adenocarcinoma in Ontario: is this related to improved endocervical Pap test sampling? Int J Cancer 2007; 120:362-7. 4. Chu J, White E. Decreasing incidence of invasive cervical cancer in young women. Am J Obstet Gynecol 1987; 157:1105-7. 5. Yang L, Huangpu XM, Zhang SW, et al. Changes of mortality rate for cervical cancer during 1970's and 1990's periods in China. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (in Chinese) 2003; 25:386-90. 6. Li H, Jin S, Xu H, et al. The decline in the mortality rates of cervical cancer and a plausible explanation in Shandong, China. Int J Epidemiol 2000; 29:398-404. 7. Chen JG, Zhang YH, Zhu J, et al. Analysis on incidence for cervical cancer in Qidong during 1972-2000. Zhonghua Fu Chan Ke Za Zhi (in Chinese) 2004; 39:505-7. 8. Office TNCRaC, ed. Cancer incidence and mortality of cities/counties for pilot study in China (1988-1992). Beijing: Chinese Medical Science and Technology Press. 2001. 9. Office TNCRaC, ed. Cancer and of cities/counties for pilot study in China (1993-1997). Beijing: Chinese Medical Science and Technology Press. 2002. 10. Office TNCRaC, ed. Cancer and of Cities/Counties for Pilot Study in China (1998-2002). Beijing: People s Medical Publication House; 2007. 11. Parkin DM, Whelan SL, Ferlay J, et al. Cancer in Five Continents. Vol. I to VIII. IARC Cancer Base No. VII. Lyon: IARC Press; 2005. 12. Curado MP, Edwards B, Shin HR, et al. Cancer in Five Continents. Vol. IX. IARC Scientific Publications No. 160. Lyon: IARC Press; 2007. 13. Zhang ZF, Parkin DM, Yu SZ, et al. Cervical screening attendance and its effectiveness in a rural population in China. Cancer Detect Prev 1989; 13:337-42. 14. van der Aa MA, Pukkala E, Coebergh JW, et al. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer 2008; 122:1854-8. 15. Jun JK, Choi KS, Jung KW, et al. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study. Int J Cancer 2009; 124:188-93. 16. Stellman SD, Wang QS. Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites. Cancer 1994; 73:1270-5. 17. Lee J, Demissie K, Lu SE, et al. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control 2007; 14:78-85. 18. Cai HB, Ding XH, Zhou YF, et al. Risk factors for cervical cancer in China: a case-control study. Eur J Gynaecol Oncol 2008; 29:72-5. 19. Ruan Y, Qin G, Yin L, et al. of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study. AIDS 2007; 21:S39-46. 20. Ruan Y, Jia Y, Zhang X, et al. of HIV-1, syphilis, hepatitis B, and hepatitis C virus infections and predictors associated with retention in a 12-month follow-up study among men who have sex with men in Beijing, China. J Acquir Immune Defic Syndr 2009; 52: 604-10.